NAP
CELG

New Amsterdam Partners’s Celgene Corp CELG Stock Holding History

New Amsterdam Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-5,202
Closed -$439K – 155
2013
Q4 		$439K Sell
5,202
-702
-12% -$55.5K 0.03% 115
2013
Q3 		$455K Sell
5,904
-25,378
-81% -$1.78M 0.03% 117
2013
Q2 		$1.83M Buy
+31,282
New +$1.88M 0.1% 113

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

New Amsterdam Partners's CELG Position: Q1 2014 in Review

New Amsterdam Partners sold out of Celgene Corp (CELG) in Q1 2014, closing a stake of 5,202 shares — an estimated $439K sold.

New Amsterdam Partners first reported a position in CELG in Q2 2013 and held it in 3 quarters. The position peaked at $1.83M in Q2 2013. 980 funds tracked by Wall St. Rank hold CELG as of Q1 2014.

  • New Amsterdam Partners reported no remaining Celgene Corp position as of Q1 2014 after selling out during the quarter.
  • New Amsterdam Partners sold 5,202 Celgene Corp shares in Q1 2014, an estimated $439K.
  • New Amsterdam Partners first reported a position in Celgene Corp in Q2 2013 and held it in 3 quarters.
  • New Amsterdam Partners's Celgene Corp position peaked at $1.83M in Q2 2013.
  • 980 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2014.

Based on New Amsterdam Partners's 13F filing for Q1 2014, filed 14 May 2014.